Your session is about to expire
← Back to Search
This trial is testing whether Qsymia can help lower blood pressure, compared to a placebo and another drug called phentermine.
- High Blood Pressure
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2009 Phase 3 trial • 2487 Patients • NCT00553787
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who qualifies as a participant in this medical trial?
"The criteria for enrollment in this trial necessitates that potential members have relatively normal blood pressure readings and are between 18-75 years old. A total of 555 participants will be recruited."
Are participants currently being recruited for this investigation?
"Affirmative. Clinicaltrials.gov records show that this medical research has been actively recruiting subjects since its inception on January 25th 2022 and the most recent update was published on November 9th, 2022. This trial requires 555 patients to be recruited across a network of 25 different sites."
Does the age criterion for this experiment include individuals below 25 years old?
"Participants must be of legal age (18 and above) yet under the age of 75 to join this clinical trial."
Are there any medical facilities in North America currently executing this clinical trial?
"Presently, 25 clinical trial sites are running this experiment. These medical centres can be found in Salt Lake City, Evanston and Baton Rouge among others. It's beneficial to select the closest location to you if participating as it helps reduce travel needs."
What health concerns arise from the ingestion of VI-0521?
"There is ample evidence suggesting VI-0521's safety, thus it received a rating of 3. This treatment has already been officially approved by regulatory bodies at the Phase 4 level."
What is the upper bound of participants in this medical experiment?
"Indeed, according to clinicaltrials.gov the study is still open for recruitment, having been initially posted on January 25th 2022 and last updated on November 9th 2022. 555 individuals are needed from a total of 25 different locations."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends